Location History:
- Berlin, DE (2014 - 2015)
- Frankfurt-am-Main, DE (2016)
Company Filing History:
Years Active: 2014-2016
Title: Cornelia Brunn: Innovator in Neurotoxin Research
Introduction
Cornelia Brunn is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of neurotoxin research, holding a total of 3 patents. Her work focuses on the development of methods and tools for the manufacturing and quality control of neurotoxins.
Latest Patents
Brunn's latest patents include innovative methods for producing highly pure neurotoxins. One of her notable inventions is an antibody that specifically binds to unprocessed and/or partially processed neurotoxin polypeptides. This invention also encompasses a composition that includes processed neurotoxin polypeptides, free from unprocessed or partially processed variants. Additionally, she has developed a system for determining the presence of unprocessed and partially processed neurotoxin type A, which is crucial for ensuring safety and quality during the manufacturing process.
Career Highlights
Cornelia Brunn is associated with Merz Pharma GmbH & Co KGaA, where she continues to advance her research in neurotoxin applications. Her work has been instrumental in enhancing the understanding and safety of neurotoxin products.
Collaborations
Brunn has collaborated with notable colleagues in her field, including Harold Victor Taylor and Karl-Heinz Eisele. These partnerships have contributed to the success and impact of her research.
Conclusion
Cornelia Brunn is a leading figure in neurotoxin research, with a focus on innovative methods for manufacturing and quality control. Her contributions are vital to the advancement of this important field.